Neurotech International Ltd (NTI) - Total Liabilities

Latest as of December 2025: AU$932.85K AUD ≈ $660.05K USD

Based on the latest financial reports, Neurotech International Ltd (NTI) has total liabilities worth AU$932.85K AUD (≈ $660.05K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Neurotech International Ltd - Total Liabilities Trend (2015–2025)

This chart illustrates how Neurotech International Ltd's total liabilities have evolved over time, based on quarterly financial data. See Neurotech International Ltd (NTI) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Neurotech International Ltd Competitors by Total Liabilities

The table below lists competitors of Neurotech International Ltd ranked by their total liabilities.

Company Country Total Liabilities
Serica Energy PLC
LSE:SQZ
UK GBX1.50 Billion
Buxton Resources Ltd
AU:BUX
Australia AU$300.90K
Suryalakshmi Cotton Mills Limited
NSE:SURYALAXMI
India Rs4.53 Billion
KGW Group Berhad
KLSE:0282
Malaysia RM21.81 Million
Sahathai Terminal Public Company Limited
BK:PORT
Thailand ฿1.74 Billion
Real Heart
ST:HEART
Sweden Skr13.59 Million
Oncozenge AB
ST:ONCOZ
Sweden Skr15.92 Million
TS Corp Preference Shares
KO:001795
Korea ₩771.33 Billion

Liability Composition Analysis (2015–2025)

This chart breaks down Neurotech International Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see NTI company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 7.30 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.16 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.14 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Neurotech International Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Neurotech International Ltd (2015–2025)

The table below shows the annual total liabilities of Neurotech International Ltd from 2015 to 2025.

Year Total Liabilities Change
2025-06-30 AU$285.74K
≈ $202.18K
-9.20%
2024-06-30 AU$314.70K
≈ $222.67K
-76.63%
2023-06-30 AU$1.35 Million
≈ $952.99K
+127.14%
2022-06-30 AU$592.98K
≈ $419.57K
-48.19%
2021-06-30 AU$1.14 Million
≈ $809.75K
+57.40%
2020-06-30 AU$727.10K
≈ $514.47K
+104.62%
2019-06-30 AU$355.33K
≈ $251.42K
-5.41%
2018-06-30 AU$375.66K
≈ $265.80K
-42.83%
2017-06-30 AU$657.04K
≈ $464.90K
-26.43%
2016-06-30 AU$893.12K
≈ $631.94K
-55.08%
2015-12-31 AU$1.99 Million
≈ $1.41 Million
--

About Neurotech International Ltd

AU:NTI Australia Biotechnology
Market Cap
$12.12 Million
AU$17.13 Million AUD
Market Cap Rank
#26583 Global
#1250 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.03
All Time High
AU$0.48
About

Neurotech International Limited, a clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company focuses on development and commercialization of NTI164 for multiple paediatric neurological disorders; and Mente, a clinically proven home therapy aimed at enhancing engagement and relaxati… Read more